← Back to Search

Other

Fortetropin Group for Osteoarthritis

N/A

Waitlist Available

Research Sponsored by MYOS Corp

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial tests a product that may help reduce joint pain and inflammation in people with osteoarthritis. Participants take the product or control daily and complete questionnaires and blood tests. Results measure pain, inflammation, and lipid levels.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Numeric Pain Rating Scale (NPRS). [Baseline to Week 12]

Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scoring. [Baseline to Week 12]

Changes in muscle mass perceived by participants. [Baseline to Week 12]

Secondary outcome measures

Changes in High-Density Lipoprotein (HDL) cholesterol. [Baseline to Week 12]

Changes in Low-Density Lipoprotein (LDL) cholesterol. [Baseline to Week 12]

Changes in blood triglycerides. [Baseline to Week 12]

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Fortetropin GroupExperimental Treatment1 Intervention

The Fortetropin group will receive a 20cc size scoop with their product and will be instructed to mix 2 scoops of product with water or a milk of their choice daily.

Group II: Control GroupPlacebo Group1 Intervention

The control group will receive a 50cc size scoop with their product and will be instructed to mix 2 scoops of product with water or a milk of their choice daily. The difference in scoop size is to allow for macronutrient matching of the intervention and control products.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CitruslabsIndustry Sponsor

68 Previous Clinical Trials

3,805 Total Patients Enrolled

MYOS CorpLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial accept individuals older than fifty years of age?

"This medical study mandates that participants must fall within the range of 50 to 75 years old. It should also be noted there are 26 trials for people under 18 and 573 studies geared towards individuals over 65 years old."

Answered by AI

Are currently enrolling for this research endeavor?

"The clinical trial posted on June 19th, 2023 is presently not accepting applicants. Last modified on August 27th, 2023 per information hosted by clinicaltrials.gov; however, there are over 600 other studies actively recruiting patients at this time."

Answered by AI

Am I eligible to partake in this research endeavor?

"This medical trial is looking for 40 participants aged 50-75, who are suffering from chronic symptoms of osteoarthritis. The enlistment criteria involve a self-report of joint pain, inflammation, reduced mobility, swelling and stiffness lasting more than 1 year as well as the ability to consume eggs without any prior medical warning. Additionally these volunteers must be willing to abstain from egg consumption during the 12 week period of research."

Answered by AI

What is the fundamental purpose of this medical experiment?

"The core objective of this 12-week trial is to quantify changes in muscle mass as perceived by participants. Furthermore, secondary metrics are being assessed and include blood triglycerides concentrations, high-density lipoprotein (HDL) cholesterol levels, and low-density lipoprotein (LDL) cholesterol values. These outcomes will be evaluated through a series of laboratory tests."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Randomized, Double-Blind, Controlled Trial to Assess the Efficacy of a Fortetropin Supplement in Improving Symptoms of Osteoarthritis

2023. "A Randomized, Double-Blind, Controlled Trial to Assess the Efficacy of a Fortetropin Supplement in Improving Symptoms of Osteoarthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06021665.